Email ID
Password
Scrip   
The patent cliff - more of a gentle slope?
22 January 2010
Peter Charlish

If the pundits are to be believed, the period between now and 2012 is set to be make-or-break time for the pharmaceutical industry, as a number of major products come off-patent. At risk are products such as Pfizer’s Lipitor (atorvastatin), Lilly’s Zyprexa (olanzapine),...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36